Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-07-10
2007-07-10
Levy, Neil S. (Department: 1615)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S565000, C514S567000, C514S615000
Reexamination Certificate
active
10351474
ABSTRACT:
The invention relates generally to the use of pharmaceutical compositions to increase milk production alone or in combination with certain biological active ingredients. Specifically, the method relates to the use of pharmaceutical compositions that will act on the feedback of the intrinsic regulatory pathway in the mammalian mammary gland. The present invention provides for as a method of increasing bovine milk production as well as a method of correcting certain human lactation abnormalities. Preferably, the compounds used in the methods of the present invention are one or more active agents capable of inhibiting peripheral aromatic amino acid decarboxylase (AADC) enzymes, peripheral tryptophan hydroxylase (TPH) enzymes, peripheral serotonin (5-HT) enzymes, or a combination of enzymes thereof.
REFERENCES:
patent: 5922341 (1999-07-01), Smith et al.
patent: 6331536 (2001-12-01), Radulovacki et al.
Petraglllia et al, Gynecol. obstet. Invest. 23: 103-109, 1987 Prolactin Changes-.
Muller etal, Prolactin -lowering and -releasing drugs.Mechanism of actin and therapeutic aplications Drugs 25/4 pp. 399-432, 1983□□□□abstract-EMBASE # 83123075.
Thulin et al. Levodopa in human breast milk; NEUROLOG 50 pp. 1920,1921 Jun. 1998.
Ben-Jonathan, N. inProlactin(ed. Horseman, N.D.) 1-24 (Kluwer Academic Publishers, Boston, 2001).
Blatchford, D.R., Hendry, K.A., Turner, M.D. Burgoyne, R.D. & Wilde, C.J., “Vectorial secretion by constitutive and regulated secretary pathways in mammary epithelial cells,”Epithelial Cell Biol, 4, 8-16 (1995).
Briskin, C., et al., “Prolactin controls mammary gland development via direct and indirect mechanisms,”Dev Biol210, 96-106 (1999).
Chapman, R.S., et al., “Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3,”Genes Dev13, 2604-2616 (1999).
Diatchenko, L. et al., “Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries,”Proc Natl Acad Sci USA, 93,6025-6030 (1996).
Hardman, J.G. and Limbird, L.E. (eds.)Goodman&Gillman's The pharmacological basis of therapeutics(McGraw-Hill, New York, 1996).
Horseman, N. D. et al., “Defective mammopoiesis, but normal hematopoiesis, in mice with a targeted disruption of the prolactin gene,”EMBO J16, 6926-6935 (1997).
Hou, M., et al., “Glycosylation-dependent cell adhesion molecule 1 (GlyCAM 1) is induced by prolactin and suppressed by progesterone in mammary epithelium,”Endocrinology141, 4278-4283 (2000).
Jerry, D.J., et al., “Delayed involution of the mammary epithelium in BALB/c-p53null mice,”Oncogene17, 2305-2312 (1998).
Kang, J. J. et al., “Transcript quantitation in total yeast cellular RNA using kinetic PCR,”Nucleic Acids Res28, e2. (2000).
Li, M., et al., “Mammary-deprived signals activate programmed cell death during the first stage of mammary gland involution,”Proc Natl Acad Sci USA94, 3425-3430 (1997).
Nguyen, A.V. and Pollard, J.W., “Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution,”Development127, 3107-3118 (2000).
Pedchenko, V. K. and Imagawa, W.T., “Mammogenic hormones differentially modulate keratinocyte growth fact (KGF)-induced proliferation and KGF receptor expression in cultured mouse mammary gland epithelium,”Endocrinology139, 2519-2526 (1998).
Stoll, J. & Goldman, D., “Isolation and structural characterization of the murine tryptophan hydroxylase gene,”J. Neurosci Res28, 457-465 (1991).
Vomachka, A.J., Pratt, S.L., Lockefeer, J.A. and Horseman, N.D., “Prolactin gene-disruption arrests mammary gland development and retards T-antigen-induced tumor growth,”Oncognen19, 1077-1084 (2000).
Wilde, C.J., Addey, C.V., Boddy, L.M. and Peaker, M., “Autocrine regulation of milk secretion by a protein in milk,”Biochem J305, 51-58 (1995).
Wilde, C.J., Knight, C.H. & Flint, D.J. “Control of milk secretion and apoptosis during mammary involution,”J Mammary Gland Biol Neoplasia, 4, 129-136. (1999).
Ayalon, Daniel, et al.; “Effect of L-Dopa on Galactopoiesis and Gonadotropin Levels in the Inappropriate Lacation Syndrome”; Journal of Obstetrics of Gynecology; Aug. 1974; pp. 159-170; vol. 44; No. 2; The American College of Obstetricians and Gynecologists.
Malarkey, William B.; “Nonpuerperal Lacation and Normal Prolactic Regulation”; JCE & M; 1975; pp. 198-204; vol. 40; No. 2; Department of Medicine, Division of Endocrinology; The Ohio State University Hospitals, Columbus, Ohio 43210.
Slatopolsky, Cantis, M., et al.; Efecto comparativo de Distintas Drogas en la Inhibicion de la Lacatancia (“In the Inhibition of the Lactation”); Spanish article with English translation; Rev. Esp. Obst. y Gin.; 1985; vol 44; pp. 447-456.
“Tablets Sinemet® (Carbidopa-Levodopa)”; Merck & Co., Inc.; Aug. 2002; pp. 1-12; Whitehouse Station, New Jersey 08889, USA.
Holmes, A., et al., “Abnormal behavioral phenotypes of serotonin transporter knockout mice: Parallels with human anxiety and depression”, Biological Psychiatry, Nov. 15, 2003, pp. 953-959, vol. 54, No. 10.
Leman, S., et al., “Density and affinity of 5-HT transporter in a mouse model of depression”, Behavioural Pharmacology, Sep. 2005, p. S44, vol. 16, No. Suppl. 1.
Matsuda, M., et al., “Serotonin Regulates Mammary Gland Development via an Autocrine-Paracine Loop”, Developmental Cell, Feb. 2004, pp. 193-203, vol. 6, Cell Press.
McManaman J.L., et al., “Mammary physiology and milk secretion”, Advanced Drug Delivery Reviews, Apr. 29, 2003, pp. 629-641, vol. 55, No. 5, Elsevier.
Nevile, M.C., et al., “LACTOGENESIS. The Transition from Pregnancy to Lactation”, Pediatric Clinics of North America, Feb. 2001, pp. 35-52, vol. 48, No. 1.
Plaut, K., et al., “Effect of Exogenous Prolactic Administration on Lactational Performance of Dairy Cows”, Domestic Animal Endocrinology, 1987, pp. 279-290, vol. 4, No. 4, Domendo, Inc.
Ramboz, S., et al., “Serotonin receptor 1A knockout: An animal model of anxiety-related disorder”, Proceedings of the National Academy of Sciences of the United States of America, 1998, pp. 11476-14481, vol. 95, No. 24.
Searce-Levie, K., et al., “5-HT receptor knockout mice: Parmacological tools or models of psychiatric disorders. Monogoraph Title: Annals of the New York Academy of Sciences; Molecular and functional diversity of ion channels and receptors”, Annals of the New York Academy of Sciences, Apr. 30, 1999, pp. 701-715, vol. 868, New York Academy of Sciences, New York, USA.
Stiening, C.M., et al., “Effect of Lactogenic Stimuli and Serotonin on Secretory Activation of Bovine Mammary Epithelial Cells (BMEC)”, The FASEB Journal, The New Biology: Reports, Reviews and FJ Express, Experimental Biology 2006®, Apr. 1-5, 2006, Abstracts Part I, Abstracts 7.1—485.10, Mar. 6, 2006, vol. 20, No. 4, San Francisco, California.
Vonderhaar, B.K., et al., “The mammary gland. A model for hormonal control of differentiation and preneoplasia”, Biological Responses in Cancer, 1985, pp. 125-159, vol. 4, Plenum Press, New York, USA.
Yancey, Jr., R.J., et al., “Efficacy of lincosaminide antibiotics in the treatment of experimental staphyloccoal mastitis in lactating mice”, Journal of Antimicrobial Chemotherapy, 1985 (Copyright 1999 Elsevier Science B.V., Amsterdam), United Kingdom.
Frost Brown Todd LLC
Levy Neil S.
University of Cincinnati
LandOfFree
Method of increasing milk production does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of increasing milk production, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of increasing milk production will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3798421